Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | B4GALT1 | P15291 | 2/20 | 0.74 |
| ▸ | P2RY14 | Q15391 | 12/20 | 0.69 |
| ▸ | P2RY2 | P41231 | 7/20 | 0.69 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.69 |
| ▸ | P2RY4 | P51582 | 6/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14583153 | 0.94 | P2RY14 (0.68) | B4GALT1P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL14088636 | 0.94 | P2RY14 (0.68) | B4GALT1P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL12015070 | 0.94 | P2RY14 (0.68) | B4GALT1P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL12361503 | 0.94 | P2RY14 (0.68) | B4GALT1P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL14414538 | 0.94 | P2RY14 (0.68) | B4GALT1P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL14178433 | 0.88 | P2RY14 (0.75) | P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL1521165 | 0.88 | P2RY14 (0.80) | P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL12108959 | 0.87 | B4GALT1 (0.61) | B4GALT1P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL14583154 | 0.86 | P2RY14 (0.79) | P2RY14P2RY2P2RY6P2RY4 | |
| SCHEMBL12361507 | 0.86 | P2RY14 (0.79) | P2RY14P2RY2P2RY6P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080206808-A1 | GALACTOSYL NUCLEOTIDE SUGAR | NEOSE TECHNOLOGIES, INC. | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206808-A1 | GALACTOSYL NUCLEOTIDE SUGAR | GALNT1, UGCG, GALNT3 | B4GALT1 24/4885P2RY14 2526/4885P2RY2 1930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.